{
  "retracted": false,
  "timestamp": 1577836800000,
  "updates": [
    {
      "timestamp": 1586904808392,
      "identifier": {
        "doi": "10.1016/j.bbmt.2019.03.006"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.bbmt.2017.04.028"
  },
  "journal": "Biology of Blood and Marrow Transplantation",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to ‘Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractory/relapsed Acute Leukemia’ [Biology of Blood and Marrow Transplantation 23/8 (2017) 1311-1319]"
}
